Cargando…
Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa
IMPORTANCE: Golimumab is a human monoclonal antibody, used for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Adverse reactions are increasing with this class of medication (tumor necrosis factor α inhibitors). OBSERVATIONS: The authors present a case of a female patient who p...
Autores principales: | Soto Lopes, Marien Siqueira, Trope, Beatriz Moritz, Rochedo Rodriguez, Maria Paula Rua, Grynszpan, Rachel Lima, Cuzzi, Tullia, Ramos-e-Silva, Marcia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843912/ https://www.ncbi.nlm.nih.gov/pubmed/24348382 http://dx.doi.org/10.1159/000350930 |
Ejemplares similares
-
Adalimumab in Recalcitrant Severe Psoriasis Associated with Atopic Dermatitis
por: Yayli, Savas, et al.
Publicado: (2013) -
Life-Threatening Gastrointestinal Mucosal Necrosis during Methotrexate Treatment for Rheumatoid Arthritis
por: Tsukada, Tomoya, et al.
Publicado: (2013) -
Chromonychia Secondary to Chemotherapy
por: Lopes, Marien, et al.
Publicado: (2013) -
Torus Palatinus Osteonecrosis Related to Bisphosphonate: A Case Report
por: Godinho, Mariana, et al.
Publicado: (2013) -
Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
por: Sharma, Neel, et al.
Publicado: (2009)